A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2001
11/29/2001	WO2001090347A1 Antiviral antisense therapy
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090316A2 Human circulating dendritic cell compositions and methods
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090251A1 Antimicrobial composition
11/29/2001	WO2001090197A1 Synthetic peptides and uses therefore
11/29/2001	WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
11/29/2001	WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
11/29/2001	WO2001090121A2 Methods and compositions for treating hepatitis c virus
11/29/2001	WO2001090111A1 New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090099A1 Fatty acid synthase inhibitors
11/29/2001	WO2001090095A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
11/29/2001	WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090064A2 COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001090035A1 Novel antibiotic compounds
11/29/2001	WO2001089562A1 F-protein epitope-based vaccine for respiratory syncytial virus infection
11/29/2001	WO2001089561A1 Aids vaccines
11/29/2001	WO2001089560A1 Inhibitors of viral infection
11/29/2001	WO2001089559A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089541A1 Use of lactobacillus casei in immunostimulatory peptides
11/29/2001	WO2001089527A2 Pharmaceutical composition comprising loratadine and a nasal decongestant
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof
11/29/2001	WO2001089509A2 Method of treating hiv-1 disease
11/29/2001	WO2001089502A2 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	WO2001089495A2 Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
11/29/2001	WO2001089364A2 Hcv variants
11/29/2001	WO2001089303A1 Methods of modulating the activity of mura
11/29/2001	WO2001089286A2 T cell binding ligand peptides, peptide constructs containing same and use thereof for treatment of immunological disorders
11/29/2001	WO2001070695A8 Pyridine derivatives as inhibitors of p38
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001049305A3 Process for obtaining thylakoids from plants, pure thylakoids and use thereof
11/29/2001	WO2001046150A3 Quinolone compounds for use in treating viral infections
11/29/2001	WO2001044465A3 Therapeutically useful synthetic oligonucleotides
11/29/2001	WO2001044272A3 Daptomycin analogs as antibacterial agents
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040198A3 Macrocyclic hydroxamic acid derivatives and their use as antimicrobial agents
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001037816A3 Coating of tablet cores
11/29/2001	WO2001034095A8 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t
11/29/2001	WO2001028996A3 Pyrrolidine derivatives, their preparation and their use as inhibitors of neuraminidases
11/29/2001	WO2001017550A3 Vaccine against hbv and hpv
11/29/2001	WO2000055159A3 Substituted aza-oxindole derivatives
11/29/2001	WO2000048633A9 Antibodies against hydrophobic proteins that are protective against candidiasis
11/29/2001	WO2000047104A9 Antagonists of hmg1 for treating inflammatory conditions
11/29/2001	WO2000041473A3 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
11/29/2001	WO2000034258A3 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
11/29/2001	US20010047080 Inhibits hiv infection of cells
11/29/2001	US20010047018 Novel benzosultam oxazolidinone antibacterial agents
11/29/2001	US20010047017 Azole derivatives
11/29/2001	US20010047006 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
11/29/2001	US20010047004 Oxazolidinone thioamides with piperazine amide substituents
11/29/2001	US20010046993 5-memberd heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists
11/29/2001	US20010046987 Potent activity against Grampositive and Gramnegative bacteria
11/29/2001	US20010046985 Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
11/29/2001	US20010046976 Antimicrobial histone h1 compositions, kits, and methods of use thereof
11/29/2001	US20010046967 Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide
11/29/2001	US20010046963 Inhibiting cyclooxygenase-2 biosynthesis and Nuclear factor kappa B synthesis; treatment of arthritis and Alzheimer's disease; administering in food
11/29/2001	US20010046957 Administering interferon-alpha or a pegylated derivative and a salt or prodrug of mycophenolic acid
11/29/2001	US20010046494 Feeding an animal a polysaccharidase enzyme selected from xylanase, cellulase and mixture, mixed with an animal feed or drinking water to treat bacterial infection
11/29/2001	US20010046481 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
11/29/2001	US20010046478 Water soluble lacquers in combination with topical and systemic antimycotics
11/29/2001	EP1143941A3 Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
11/29/2001	DE10025045A1 Mittel zur Stimulation des Immunsystems Means for stimulation of the immune system
11/29/2001	CA2712547A1 Methods and compositions for treating hepatitis c virus
11/29/2001	CA2429199A1 Drug metabolizing enzymes
11/29/2001	CA2410593A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	CA2410567A1 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	CA2410350A1 Use of lactobacillus casei in immunostimulatory compounds
11/29/2001	CA2410294A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	CA2409929A1 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes
11/29/2001	CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	CA2409873A1 Hcv variants
11/29/2001	CA2409772A1 Antiviral therapy
11/29/2001	CA2409430A1 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	CA2409367A1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/29/2001	CA2409259A1 Novel antibiotic compounds
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2408749A1 Drug screening systems and assays
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.

1 ... 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 ... 1798